An S F, Fleming K A
Nuffield Department of Pathology and Bacteriology, University of Oxford, John Radcliffe Hospital.
J Clin Pathol. 1991 Nov;44(11):924-7. doi: 10.1136/jcp.44.11.924.
A problem associated with use of the polymerase chain reaction to amplify specific DNA fragments from formalin fixed, paraffin wax embedded tissues is the not infrequent failure of amplification. One possible reason for this could be the presence of inhibitor(s), which interfere with the activity of the reaction. It has been shown that such inhibitor(s) exist when amplifying the human beta globin gene (which exists in human genomic DNA as a single copy gene) from routine clinical samples. A variety of methods to remove such inhibitor(s) were investigated. The results indicate that inhibitor(s) are removed by proteinase K digestion, followed by purification with phenol/chloroform, and centrifugation through a Centricon-30 membrane (30,000 molecular weight cut off). Other factors, including the length and concentration of the DNA sequence to be amplified, can also affect amplification.
使用聚合酶链反应从福尔马林固定、石蜡包埋组织中扩增特定DNA片段时,一个与之相关的问题是扩增常常失败。造成这种情况的一个可能原因是存在抑制剂,其会干扰反应活性。研究表明,从常规临床样本中扩增人类β珠蛋白基因(该基因在人类基因组DNA中以单拷贝基因形式存在)时存在此类抑制剂。研究了多种去除此类抑制剂的方法。结果表明,通过蛋白酶K消化,随后用苯酚/氯仿纯化,并通过Centricon - 30膜(截留分子量30,000)离心,可以去除抑制剂。其他因素,包括待扩增DNA序列的长度和浓度,也会影响扩增。